Tempus AI (TEM) Earnings Yield: History & Chart

Tempus AI, Inc.(TEM)

Medical - Healthcare Information Services · Chicago, IL

$58.74+0.00 (+0.00%)

Delayed quote: Sep 10, 2026, 4:00 PM EDT

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$10.29B	N/A	N/A	N/A	N/A
Molina Healthcare, Inc. (MOH)vs ›	$10.45B	0.09%	6.03%	6.15%	5.36%
Universal Health Services, Inc. (UHS)vs ›	$10.46B	14.12%	11.96%	9.03%	8.80%
The Ensign Group, Inc. (ENSG)vs ›	$10.07B	3.69%	3.26%	3.35%	3.73%
The Cooper Companies, Inc. (COO)vs ›	$10.56B	N/A	2.46%	2.15%	10.62%
Henry Schein, Inc. (HSIC)vs ›	$9.94B	3.93%	4.25%	4.25%	4.71%
Bio-Rad Laboratories, Inc. (BIO)vs ›	$9.93B	2.24%	4.85%	4.76%	14.20%
Globus Medical, Inc. (GMED)vs ›	$9.92B	5.29%	4.40%	2.72%	2.66%
Align Technology, Inc. (ALGN)vs ›	$10.79B	3.82%	3.51%	2.85%	2.60%
Insulet Corp. (PODD)vs ›	$9.33B	3.97%	1.90%	1.77%	1.21%

NAME

MARKET CAP

EARNINGS YIELD

TTM

Tempus AI, Inc. (TEM)

$10.29B

N/A

Molina Healthcare, Inc. (MOH)vs ›

$10.45B

0.09%

6.03%

6.15%

5.36%

Universal Health Services, Inc. (UHS)vs ›

$10.46B

14.12%

11.96%

9.03%

8.80%

The Ensign Group, Inc. (ENSG)vs ›

$10.07B

3.69%

3.26%

3.35%

3.73%

The Cooper Companies, Inc. (COO)vs ›

$10.56B

N/A

2.46%

2.15%

10.62%

Henry Schein, Inc. (HSIC)vs ›

$9.94B

3.93%

4.25%

4.71%

Bio-Rad Laboratories, Inc. (BIO)vs ›

$9.93B

2.24%

4.85%

4.76%

14.20%

Globus Medical, Inc. (GMED)vs ›

$9.92B

5.29%

4.40%

2.72%

2.66%

Align Technology, Inc. (ALGN)vs ›

$10.79B

3.82%

3.51%

2.85%

2.60%

Insulet Corp. (PODD)vs ›

$9.33B

3.97%

1.90%

1.77%

1.21%

Earnings Yield: N/A

TEM Earnings Yield Metrics

TEM Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics